Distinct patterns of gene expression induced by viral oncogenes in human embryonic brain cells

Cellular and Molecular Neurobiology

Volumn 23, Issue 1, 2003, Pages 27-42

  Nahreini, Piruz ^a   Andreatta, Cynthia ^a   Kumar, Bipin ^a   Hanson, Amy ^a   Edwards Prasad, Judith ^a   Freed, Curt R ^a   Prasad, Kedar N ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CAMP; Differentiation; E6E7; EGFP; Extended lifespan; Neuron; P14ARF; P16 (INK4a); P21 (WAF1); P27 (Kip1); P53; Retroviral transduction; SV40 LTA

Indexed keywords

CYCLIC AMP; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; RNA; VIRUS LARGE T ANTIGEN;

ARTICLE; BRAIN CELL; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION; DEGENERATIVE DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; LIFESPAN; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE; WART VIRUS;

ANIMALS; BRAIN; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; EMBRYO; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; ONCOGENES; PAPILLOMAVIRIDAE; SIMIAN VIRUS 40;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; SIMIAE; SIMIAN VIRUS 40;

EID: 0037303538     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022541017085     Document Type: Article

References (39)

1. Chin, L., Pomerantz, J., and DePinho, R. A. (1998). The INK4a/ARF tumor suppressor: One gene-two products-two pathways. Trends Biochem. Sci. 23:291-296.
2. Clarkson, E. D., and Freed, C. R. (1999). Development of fetal neural transplantation as a treatment for Parkinson's disease. Life Sci. 65:2427-2437.
3. Dorsky, R. I., Moon, R. T., and Raible, D. W. (2000). Environmental signals and cell fate specification in premigratory neural crest. Bioessays 22:708-716.
4. Foster, S. A., Wong, D. J., Barrett, M. T., and Galloway, D. A. (1998). Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18:1793-1801.
5. Freed, C. R. (2002). Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc. Natl. Acad. Sci. U.S.A. 99:1755-1757.
6. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100:57-70.
7. Hansen, T. O., Rehfeld, J. F., and Nielsen, F. C. (2000). Cyclic AMP-induced neuronal differentiation via activation of p38 mitogen-activated protein kinase. J. Neurochem. 75:1870-1877.
8. Harms, W., Rothamel, T., Miller, K., Harste, G., Grassmann, M., and Heim, A. (2001). Characterization of human myocardial fibroblasts immortalized by HPV16 E6-E7 genes. Exp. Cell Res. 268:252-261.
9. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
10. Huschtscha, L. I., Neumann, A. A., Noble, J. R., and Reddel, R. R. (2001). Effects of simian virus 40 T-antigens on normal human mammary epithelial cells reveal evidence for spontaneous alterations in addition to loss of p16 (INK4a) expression. Exp. Cell Res. 265:125-134.
11. Imperiale, M. J. (2001). Oncogenic transformation by the human polyomaviruses. Oncogene 20:7917-7923.
12. Ivanchuk, S. M., Mondal, S., Dirks, P. B., and Rutka, J. T. (2001). The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth. J. Neurooncol. 51:219-229.
13. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387:299-303.
14. Kumar, B., Hovland, A. R., Prasad, J. E., Clarkson, E., Cole, W. C., Nahreini, P., Freed, C. R., and Prasad, K. N. (2001). Establishment of human embryonic brain cell lines. In Vitro Cell Dev. Biol. Anim. 37:259-262.
15. Kurokawa, K., Tanaka, T., and Kato, J. (1999). p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts. Oncogene 18:2718-2727.
16. Lundberg, A. S., and Weinberg, R. A. (1999). Control of the cell cycle and apoptosis. Eur. J. Cancer 35:1886-1894.
17. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
18. Mal, A., Poon, R. Y., Howe, P. H., Toyoshima, H., Hunter, T., and Harter, M. L. (1996). Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature 380:262-265.
19. Mantovani, F., and Banks, L. (2001). The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
20. McCaffery, P., and Drager, U. C. (2000). Regulation of retinoic acid signaling in the embryonic nervous system: A master differentiation factor. Cytokine Growth Factor Rev. 11:233-249.
21. Medema, R. H., Herrera, R. E., Lam, F., and Weinberg, R. A. (1995). Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. U.S.A. 92:6289-6293.
22. Munger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., and Zacny, V. L. (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
23. Nahreini, P., Hovland, A. R., Kumar, B., Andreatta, C., Edwards-Prasad, J., and Prasad, K. N. (2001). Effects of altered cyclophilin A expression on growth and differentiation of human and mouse neuronal cells. Cell. Mol. Neurobiol. 21:65-79.
24. Obermeier, A., Bradshaw, R. A., Seedorf, K., Choidas, A., Schlessinger, J., and Ullrich, A. (1995). Definition of signals for neuronal differentiation. Ann. N.Y. Acad. Sci. 766:1-17.
25. Patapoutian, A., and Reichardt, L. F. (2000). Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol. 10:392-399.
26. Prasad, K. N. (1991). Differentiation of neuroblastoma cells: A useful model for neurobiology and cancer. Biol. Rev. 66:431-451.
27. Prives, C., and Hall, P. A. (1999). The p53 pathway. J. Pathol. 187:112-126.
28. Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen K., Orlow, I., Lee, H. W., Cordon-Cardo, C., DePinho, R. A. (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-723.
29. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
30. Reddel, R. R. (1998). Genes involved in the control of cellular proliferative potential. Ann. N.Y. Acad. Sci. 854:8-19.
31. Robertson, K. D., and Jones, P. A. (1998). The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18:6457-6473.
32. Saenz-Robles, M. T., Sullivan, C. S., and Pipas, J. M. (2001). Transforming functions of Simian Virus 40. Oncogene 20:7899-7907.
33. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831-2841.
34. Sashiyama, H., Shino, Y., Kawamata, Y., Tomita, Y., Ogawa, N., Shimada, H., Kobayashi, S., Asano, T., Ochiai, T., and Shirasawa, H. (2001). Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16. Int. J. Oncol. 19:97-103.
35. Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., and Howley, P. M. (1992). Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J. Virol. 66:5100-5105.
36. Svendsen, C. N., and Smith, A. G. (1999). New prospects for human stem-cell therapy in the nervous system. Trends Neurosci. 22:357-364.
37. Whalen, B., Laffin, J. Friedrich, T. D., and Lehman, J. M. (1999). SV40 small T antigen enhances progression to >G2 during lytic infection. Exp. Cell. Res. 251:121-127.
38. Zerfass-Thome, K., Zwerschke, W., Mannhardt, B., Tindle, R., Botz, J. W., and Jansen-Durr, P. (1996). Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330.
39. Zhang, Y., Xiong, Y., and Yarbrough, W. G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734.